{"url_path":"/sec/ensc/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1716947/0001493152-26-023811-index.html","accession_number":"0001493152-26-023811","cik":"0001716947","ticker":"ENSC","issuer_name":"Ensysce Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1716947/0001493152-26-023811-index.html","primary_entity_key":"0001716947","primary_entity_name":"Ensysce Biosciences, Inc."},"word_count":131,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings.**\n\n \n\nFrom\ntime to time, we could become involved in disputes and various litigation matters that arise in the normal course of business. These\nmay include disputes and lawsuits related to intellectual property, licensing, contract law and employee relations matters. Periodically,\nwe review the status of significant matters, if any exist, and assesses its potential financial exposure. If the potential loss from\nany claim or legal claim is considered probable and the amount can be estimated, we accrue a liability for the estimated loss. Legal\nproceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based\non the best information available at the time. As additional information becomes available, we reassess the potential liability related\nto pending claims and litigation."}